Evidence map›Paper›PMID 21141891›Full record

ArticleMolecular pharmaceutics2011

Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin.

Timothy P Day, Diptesh Sil, Nikunj M Shukla, Asokan Anbanandam, Victor W Day, Sunil A David

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Timothy P DayDepartment of Medicinal Chemistry, Delbert M. Shankel Structural Biology Center, and The Small-Molecule X-ray Crystallography Laboratory, University of Kansas, Lawrence, Kansas 66047, USA.
Diptesh Sil
Nikunj M Shukla
Asokan Anbanandam
Victor W Day
Sunil A David
University of Kansas · US

Funding

TRAFFICKING OF THE PLASMA MEMBRANE CA2+-ATPASE TO RAFTSP20RR017708 · NCRR · UNIVERSITY OF KANSAS LAWRENCE · PI FISCHER, CHRISTOPHER JAMES · 2002 to 2011
$20.1M
MBRS IMSD PROGRAM AT THE UNIVERSITY OF KANSASR25GM062232 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI CARTWRIGHT, PAULYN, HANSON, PAUL R. · 2001 to 2018
$6.9M
Preclinical development of DS-96, a novel alkylpolyamine endotoxin squestrantU01AI077947 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI DAVID, SUNIL A · 2008 to 2012
$1.8M
NCRR NIH HHS P20 RR017708NIAID NIH HHS U01 AI077947NIGMS NIH HHS 5R25GM062232)NIGMS NIH HHS R25 GM062232
6 · The paper itself

Abstract

Aqueous solubilities of many drugs in current clinical use are very low, necessitating formulations that often present problems for parenteral administration, including toxicities due to the excipients used. Recognizing that pharmacologically active compounds frequently possess amines, we asked whether pyridoxal phosphate (PLP), an inoccuous, water-soluble vitamin, could be utilized to form prodrug-like complexes via the formation of imine or iminium adducts and whether the vitamin would impart solubilizing properties to such complexes. Direct spectroscopic and crystallographic data obtained using model primary and secondary amines showed that PLP forms stable imine adducts with primary amines under entirely aqueous conditions and at physiologic pH, while no reaction was observed for secondary amines; the basis of the exceptional stability appears to be a consequence of favorable H-bond interactions of the imine nitrogen with the 5-OH group of PLP. Amphotericin B and nystatin in their native forms display marked aqueous insolubility and possess lone primary amines. We were able to utilize PLP in achieving excellent solubilization of both of these antifungal agents, surpassing aqueous solubilities of 100 mg/mL. In in vitro bioassays, both polyenes in their PLP-adducted form display attenuated antifungal potencies which are attributable to "prodrug-like" complexes. These results point to the utility of excipient-free, entirely aqueous formulations of amphotericin B for parenteral use, and may also be extended to other primary amine-bearing compounds exhibiting poor aqueous solubility.

Indexed as

Amphotericin BNystatinProdrugsPyridoxal PhosphateSolubilityAmphotericin BNystatinProdrugsPyridoxal Phosphate

Identifiers

PMID21141891
PMCPMC3034802
OpenAlexW2004917978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.